CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute. (Q39505275)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Gabriele Zoppoli

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Stéphanie Solier

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

William Reinhold

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

H Liu

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

J W Connelly

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

A Monks

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

R H Shoemaker

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

O D Abaan

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

P S Meltzer

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

J H Doroshow

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Y Pommier

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

0 references

publication date

18 July 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

403-418

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

https://scigraph.springernature.com/pub.10.1038/onc.2011.283

0 references

Phosphorylation of HuR by Chk2 regulates SIRT1 expression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Checkpoint kinase 2 (Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage regardless of threonine 68 phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

The Chk2 protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

CHK2 kinase--a busy messenger.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Chk1 and Chk2 kinases in checkpoint control and cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

GammaH2AX and cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

ATM activation is accompanied with earlier stages of prostate tumorigenesis.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Activated checkpoint kinase 2 provides a survival signal for tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

DNA damage checkpoint kinase Chk2 triggers replicative senescence

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Genome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisons

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

The DNA damage response: ten years after

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide].

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Regulation of CHK2 by DNA-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Chk2 oligomerization studied by phosphopeptide ligation: implications for regulation and phosphodependent interactions

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

The CHEK2 gene and inherited breast cancer susceptibility

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

SIFT: Predicting amino acid changes that affect protein function

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Targeting chk2 kinase: molecular interaction maps and therapeutic rationale

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

A gene expression database for the molecular pharmacology of cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

GammaH2AX in cancer cells: a potential biomarker for cancer diagnostics, prediction and recurrence

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

The NCI60 human tumour cell line anticancer drug screen

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

The apoptotic ring: a novel entity with phosphorylated histones H2AX and H2B and activated DNA damage response kinases

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Alternative splicing and mutation status of CHEK2 in stage III breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Chk2 activates E2F-1 in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Concomitant inactivation of p53 and Chk2 in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Centrosomal localization of DNA damage checkpoint proteins

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Cytometric assessment of DNA damage by exogenous and endogenous oxidants reports aging-related processes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Kinetics of histone H2AX phosphorylation and Chk2 activation in A549 cells treated with topotecan and mitoxantrone in relation to the cell cycle phase

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Detection of in vitro kinase generated protein phosphorylation sites using gamma[18O4]-ATP and mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

21 January 2018

Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

31 March 2020

Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

31 March 2020

Human DNA damage checkpoints and their relevance to soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

31 March 2020

Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

31 March 2020

Chk2 molecular interaction map and rationale for Chk2 inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

31 March 2020

Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.283

31 March 2020

Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21765476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21765476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21765476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21765476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21765476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Karyotypic complexity of the NCI-60 drug-screening panel.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21765476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/21765476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53

1 reference

https://pubmed.ncbi.nlm.nih.gov/21765476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of checkpoint kinase 2 in breast carcinomas: correlation with key regulators of tumor cell proliferation, angiogenesis, and survival.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21765476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/ONC.2011.283

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21765476%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39505275&oldid=1460059521"